Gardasil Vaccine Age Recommendations
The Gardasil vaccine can be given to individuals from age 9 through 45 years, with routine vaccination recommended for all persons through age 26 years and shared clinical decision-making recommended for adults aged 27 through 45 years. 1
Optimal Vaccination Age and Schedule
Routine Vaccination
- Primary target population: Ages 11-12 years 1
- Starting age: Can be given as early as 9 years of age 1
- Catch-up vaccination: Recommended for all persons through age 26 years 1
Dosing Schedule
- Ages 9-14 years: 2-dose schedule (doses at 0 and 6-12 months) 2
- If second dose is given earlier than 5 months after first dose, a third dose is needed
- Ages 15-45 years: 3-dose schedule (doses at 0,2, and 6 months) 2
- Immunocompromised individuals: 3-dose schedule regardless of age 1
Vaccination Beyond Age 26
For adults aged 27-45 years, the Advisory Committee on Immunization Practices (ACIP) does not recommend routine catch-up vaccination but supports shared clinical decision-making 1. This recommendation is based on:
- Most sexually active adults have already been exposed to HPV
- New infections can still occur with new sexual partners
- The vaccine is only effective against HPV types not previously acquired
Factors to consider for vaccination in the 27-45 age group include:
- Risk for new HPV infection (new sexual partners)
- History of previous HPV-related disease
- Immunocompromised status 1
Special Populations
- Immunocompromised individuals: Recommended through age 26 years with a 3-dose schedule 1
- Men who have sex with men: Recommended through age 26 years 1
- Pregnant women: Vaccination should be postponed until after pregnancy 1
Clinical Considerations
Efficacy Considerations
- Antibody responses are highest in individuals aged 9-15 years 1
- The vaccine is most effective when given before sexual debut and potential HPV exposure 1
- The vaccine does not treat existing HPV infections or HPV-related disease 2
Common Pitfalls to Avoid
- Delaying vaccination: Maximum benefit occurs when administered before sexual activity begins
- Stopping cervical cancer screening: Vaccinated women should continue routine cervical cancer screening as recommended 1
- Assuming complete protection: The vaccine only protects against the included HPV types (6,11,16,18,31,33,45,52, and 58 for the 9-valent vaccine) 1
- Administering during pregnancy: Although not contraindicated, vaccination should ideally be postponed until after pregnancy 1
Safety
- The vaccine is generally well-tolerated with headache being the most common side effect
- Syncope (fainting) can occur; patients should be observed for 15 minutes after administration 2
- Contraindicated in individuals with history of immediate hypersensitivity to yeast or any vaccine component 1
The Gardasil vaccine represents an important tool for preventing HPV-related cancers and diseases, with optimal protection achieved through vaccination at the recommended ages.